Shanghai Menon Animal Nutrition Technology Co., Ltd. (SHE:301156)
China · Delayed Price · Currency is CNY 13.15
-4.85 (-26.94%)
May 29, 2026, 3:04 PM CST
SHE:301156 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 610.08 | 550.91 | 489.39 | 497.95 | 470.12 | 540.85 |
Other Revenue | 10.36 | 10.36 | 0.54 | 6.47 | 13.19 | 5.4 |
| 620.44 | 561.27 | 489.93 | 504.42 | 483.32 | 546.25 | |
Revenue Growth (YoY) | 26.14% | 14.56% | -2.87% | 4.37% | -11.52% | 29.89% |
Cost of Revenue | 429.8 | 392.57 | 350.27 | 354.56 | 344.25 | 385.77 |
Gross Profit | 190.63 | 168.69 | 139.66 | 149.86 | 139.07 | 160.49 |
Selling, General & Admin | 91.81 | 85.63 | 69.76 | 72.83 | 61.67 | 63.74 |
Research & Development | 25.6 | 24.84 | 20.88 | 21.97 | 21.38 | 22.53 |
Other Operating Expenses | 2.48 | 2.19 | 2.04 | 2.39 | 2.06 | 2.02 |
Operating Expenses | 122.92 | 113.71 | 94.05 | 94.53 | 87.55 | 87.81 |
Operating Income | 67.71 | 54.98 | 45.61 | 55.33 | 51.52 | 72.68 |
Interest Expense | -0.01 | -0.01 | - | - | -0.69 | -1.12 |
Interest & Investment Income | 4.52 | 4.28 | 3.3 | 8.01 | 2.61 | 3.13 |
Currency Exchange Gain (Loss) | -1.21 | -1.21 | 2.33 | 0.93 | 4.34 | -1.46 |
Other Non Operating Income (Expenses) | -2.78 | -0.3 | -0.21 | 0.11 | -0.39 | -0.23 |
EBT Excluding Unusual Items | 68.24 | 57.74 | 51.02 | 64.38 | 57.38 | 73 |
Gain (Loss) on Sale of Investments | -0.22 | -0.22 | 1.32 | -0.01 | -0.72 | 0.39 |
Gain (Loss) on Sale of Assets | -0.01 | -0 | 0.35 | 0.03 | -0.02 | -0 |
Asset Writedown | -6.58 | -0.15 | -0.04 | - | - | -0.08 |
Other Unusual Items | 3.9 | 3.4 | 3.14 | 5.82 | 1.64 | 6.21 |
Pretax Income | 65.34 | 60.77 | 55.8 | 70.22 | 58.28 | 79.53 |
Income Tax Expense | 5.96 | 5.96 | 6.22 | 7.17 | 5.79 | 8.97 |
Net Income | 59.38 | 54.81 | 49.58 | 63.05 | 52.49 | 70.56 |
Net Income to Common | 59.38 | 54.81 | 49.58 | 63.05 | 52.49 | 70.56 |
Net Income Growth | 21.48% | 10.54% | -21.35% | 20.11% | -25.60% | 5.76% |
Shares Outstanding (Basic) | 183 | 183 | 187 | 189 | 166 | 141 |
Shares Outstanding (Diluted) | 183 | 183 | 187 | 189 | 166 | 141 |
Shares Change (YoY) | -1.46% | -2.07% | -0.80% | 13.96% | 17.08% | -0.52% |
EPS (Basic) | 0.32 | 0.30 | 0.26 | 0.33 | 0.32 | 0.50 |
EPS (Diluted) | 0.32 | 0.30 | 0.26 | 0.33 | 0.32 | 0.50 |
EPS Growth | 23.28% | 12.88% | -20.72% | 5.40% | -36.45% | 6.31% |
Free Cash Flow | -68.99 | -51.36 | 11.22 | 21.56 | -7.63 | -35.76 |
Free Cash Flow Per Share | -0.38 | -0.28 | 0.06 | 0.11 | -0.05 | -0.25 |
Dividend Per Share | 0.231 | 0.231 | 0.246 | 0.423 | 0.254 | - |
Dividend Growth | -6.25% | -6.25% | -41.81% | 66.84% | - | - |
Gross Margin | 30.73% | 30.06% | 28.51% | 29.71% | 28.77% | 29.38% |
Operating Margin | 10.91% | 9.80% | 9.31% | 10.97% | 10.66% | 13.30% |
Profit Margin | 9.57% | 9.77% | 10.12% | 12.50% | 10.86% | 12.92% |
Free Cash Flow Margin | -11.12% | -9.15% | 2.29% | 4.28% | -1.58% | -6.55% |
EBITDA | 94.45 | 81.05 | 69.02 | 74.59 | 61.48 | 80.48 |
EBITDA Margin | 15.22% | 14.44% | 14.09% | 14.79% | 12.72% | 14.73% |
D&A For EBITDA | 26.73 | 26.07 | 23.41 | 19.26 | 9.96 | 7.8 |
EBIT | 67.71 | 54.98 | 45.61 | 55.33 | 51.52 | 72.68 |
EBIT Margin | 10.91% | 9.80% | 9.31% | 10.97% | 10.66% | 13.30% |
Effective Tax Rate | 9.12% | 9.81% | 11.14% | 10.22% | 9.94% | 11.28% |
Revenue as Reported | 620.44 | 561.27 | 489.93 | 504.42 | 483.32 | 546.25 |
Advertising Expenses | - | 1.22 | 1.95 | 1.82 | 0.36 | 0.35 |